FOXI3 Inhibitors
Chemical inhibitors of FOXI3 can exert their inhibitory effects through various biochemical and cellular pathways, each affecting the protein's function in a distinct manner. LY294002 and Wortmannin, for example, are both inhibitors of PI3K, and their action can lead to a decrease in AKT signaling. Since AKT is a key player in the translocation and activation of numerous transcription factors, its inhibition can reduce FOXI3 activity due to a decreased activation state of transcription factors that might otherwise enhance FOXI3 function. Similarly, PD98059 and U0126 are selective inhibitors of MEK1/2, a part of the MAPK/ERK pathway, which is crucial for the phosphorylation and subsequent activation of various transcription factors. By preventing MEK activation, these inhibitors can decrease the phosphorylation and activity of transcription factors that regulate or interact with FOXI3, thereby reducing its functional activity.
Additionally, SB203580 specifically targets p38 MAPK, another stress-responsive kinase that influences transcription factor activity. The inhibition of p38 MAPK can alter the phosphorylation landscape and activity of transcription factors that may directly or indirectly control FOXI3 function. SP600125 inhibits JNK, thereby affecting transcription factors regulated by JNK pathways, which can decrease FOXI3 activity. On the other hand, inhibitors like Roscovitine target cyclin-dependent kinases (CDKs) and can impinge on cell cycle-related transcription factors, potentially impacting FOXI3 activity due to alterations in the regulatory network. Curcumin is known to affect the NF-kB signaling pathway, and by doing so, can reduce activation of transcription factors that are crucial for FOXI3 function. Furthermore, chemicals like Cycloheximide, Anisomycin, and Emetine, which inhibit protein synthesis, can reduce the levels of proteins essential for the proper function of transcription factors, thus possibly diminishing FOXI3 activity. Lastly, Rapamycin, a specific inhibitor of mTORC1, can also lead to reduced protein synthesis and affect transcription factor activity, which in turn can reduce the functional activity of FOXI3 due to a lessened phosphorylation state.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of phosphoinositide 3-kinases (PI3Ks). By inhibiting PI3K, it affects the PI3K/AKT signaling pathway, which is involved in various cellular processes including transcription factor regulation. Inhibition of this pathway can lead to reduced activity of transcription factors like FOXI3, as PI3K influences the translocation and activity of multiple transcription factors within the nucleus. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another potent PI3K inhibitor that irreversibly inhibits the enzyme, impacting the PI3K/AKT pathway similarly to LY294002. This inhibition can result in decreased nuclear activities of transcription factors, such as FOXI3, due to impaired translocation and reduced activation of these transcription factors. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of mitogen-activated protein kinase kinase (MEK), which is a part of the MAPK/ERK pathway. Inhibition of MEK leads to a decrease in ERK phosphorylation and activity, potentially reducing the activation and function of transcription factors, including FOXI3, that are regulated via this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK. The p38 MAPK pathway is involved in the response to stress stimuli and influences the activity of various transcription factors. Inhibition of p38 MAPK can decrease the functional activity of FOXI3 by altering the phosphorylation state and activity of transcription factors modulated by this pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which is part of the MAPK signaling pathways. By inhibiting JNK, SP600125 can affect transcription factors regulated by JNK, potentially diminishing the activity of FOXI3 as a result of altered transcription factor dynamics. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Roscovitine is a selective inhibitor of cyclin-dependent kinases (CDKs). By inhibiting CDKs, it can affect the cell cycle and the phosphorylation state of various proteins, including transcription factors. This can lead to a functional inhibition of FOXI3 activity due to changes in the regulatory network of the cell cycle that may impact transcription factor function. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin is known to inhibit a wide range of kinases and has been shown to affect the NF-kB signaling pathway. By inhibiting this pathway, Curcumin can reduce the activation of several transcription factors, conceivably leading to decreased FOXI3 activity due to a lower level of transcription factor activation. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits eukaryotic protein synthesis by interfering with the translocation step in protein synthesis, thus inhibiting translational elongation. This inhibition can reduce the overall protein synthesis, potentially decreasing the availability and activity of various proteins including transcription factors, which in turn could diminish FOXI3 function due to reduced protein-protein interactions. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a pyrrolidine antibiotic that inhibits eukaryotic protein synthesis. Similar to Cycloheximide, by inhibiting peptide elongation, it can decrease the levels of proteins necessary for the proper function of transcription factors, potentially leading to a functional inhibition of FOXI3. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $440.00 $900.00 $1400.00 $2502.00 | ||
Emetine is an alkaloid that inhibits protein synthesis by blocking the movement of the ribosome along mRNA. This inhibition can lead to a decrease in the synthesis of proteins necessary for the activation and function of transcription factors, which could result in a decrease in FOXI3 activity. | ||||||